[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.39.7. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1962

Histamine Liberation by Codeine and Polymyxin B in Urticaria Pigmentosa

Author Affiliations

WINNIPEG, MAN., CANADA

Teaching Fellows, Department of Pharmacology and Therapeutics, University of Manitoba (Dr. Sutter and Mr. Beaulieu); Research Fellow, Medical Research Council of Canada (Dr. Sutter); Assistant Professor of Medicine (Dermatology), University of Manitoba (Dr. Birt).

Arch Dermatol. 1962;86(2):217-221. doi:10.1001/archderm.1962.01590080087011
Abstract

Urticaria pigmentosa, a cutaneous form of mastocytosis, is associated with the excretion of above normal amounts of histamine in the urine.1,2 It is estimated that approximately one-third of patients with this condition experience spontaneous attacks of flushing of the skin,1 and it is thought that this flushing is due to release of histamine from the mast cells. If this is true, the administration of a histamine liberator to these patients should produce flushing, and repeated administration of such an agent might maintain the mast cells in a state of histamine depletion, thus preventing further flushing attacks and whealing of the local lesions.

Codeine3 and polymyxin B4,5 are 2 potent histamine liberators, the latter being particularly specific for histamine. This paper reports observations on the effects of these 2 agents administered to 5 patients with mastocytosis. Total urinary histamine excretion was measured in one case. In this

×